We investigate structure-activity effect relationships at the nanoscale chiral molecular recognition interface between enantiomeric self-assembled multivalent (SAMul) systems and biological polyanions, heparin and DNA. 
Molecular recognition at self-assembled surfaces is a key strategy used by biological systems to organise ligands over nanometre length scales, enabling adhesion to biomolecular targets. 1 There is increasing interest in synthetic supramolecular systems which bind nanoscale biological targets, 2 with multivalent binding being of particular use. Self-assembly is a powerful strategy to organise such interactions. 4 We have been developing self-assembled multivalent (SAMul) systems to bind polyanions such as DNA 5 and heparin, 6 which have potential clinical relevance in gene therapy, 7 and blood coagulation control, 8 respectively. More broadly, it is worth noting that there are many polyanions in biological systems including cell membranes, microfilaments and tubules. Biology can control these polyanions with precise selectivity understanding and intervening in this remains a real challenge. 9 Self-assembled polycations are widely used to bind polyanions.
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Selectivity at such binding interfaces is primarily considered to be based on charge density; 11 other factors are known to modulate selectivity, but the number of experimental examples is limited. 12 We have therefore been interested in exploring the subtleties of polyanion recognition.
We recently studied ligand modification in SAMul systems and found different polyanions exhibited different ligand preferences. 13 We have also studied chiral systems, and found ligand chirality could enable enantioselective binding. 14 Chiral micelles are known to separate enantiomers in capillary electrophoresis, with the low-molecular-weight analyte partitioning into the micelle, close to the surfactant chiral centre, 15 but this is somewhat different to our report of chiral multivalent binding across the self-assembled surface.
14 However, the molecular structures in our previous report were relatively complex, and we therefore wanted to simplify our molecular design to probe the impact of simple structural modifications on chiral ligand display. In our new minimal design, Boc-protected L-or D-Lysine was coupled with 1-hexadecylamine using TBTU and Et 3 N in DCM, with the desired compounds C 16 -L-Lys and C 16 -D-Lys being obtained after removal of the protecting groups using HCl gas in methanol. Similarly, the glycine-spaced compounds were synthesised using solution-phase TBTU-mediated peptide coupling and a Boc-protecting group strategy (see ESI). The syntheses worked in good yields, with circular dichroism (CD) spectroscopy being used to confirm enantiomeric relationships; each pair of compounds exhibited mirror-image spectra (Table 1 and ESI). The CD spectra of the compounds with and without a glycine spacer were different, reflecting the presence of the additional UV-chromophoric peptide bond.
We probed the critical aggregation concentrations (CACs) using a Nile Red assay in PBS buffer. 16 The CACs of C 16 -L-Lys and C 16 -D-Lys were 33 ± 3 M 29 ± 4 M respectively, while those of C 16 -Gly-L-Lys and C 16 -Gly-D-Lys were 31 ± 3 M and 28 ± 3 M ( Transmission electron microscopy (TEM) was used to visualise the self-assembled morphologies formed on drying aqueous solutions. All four compounds aggregated into similar micellar assemblies, with approximate diameters of ca. 8 nm ( Fig. 3 and ESI). Dynamic light scattering (DLS) was used to further characterise these self-assembled nanostructures in solution (Table 1 ). Both C 16 -L-Lys and C 16 -D-Lys formed aggregates ca. 6.3 nm in diameter, assigned as spherical micelles. Perhaps surprisingly, however, C 16 -Gly-L-Lys and C 16 -Gly-D-Lys appeared to form larger solution-phase assemblies with diameters of ca. 120 nm and ca. 83 nm respectively, and large size distributions. Clearly C 16 -Gly-L-Lys and C 16 -Gly-D-Lys are more prone than C 16 -L-Lys and C 16 -D-Lys to further aggregation, which must stem from the molecular-level insertion of the glycine spacer. However, DLS was performed at elevated concentrations (0.5 mg ml -1 , 1 mM) which can impact on self-assembled morphology. We therefore also performed DLS at lower concentrations (down to 100 M) to better reflect assay conditions, and found much greater contribution from smaller nanostructures (see ESI).
The zeta potentials of C 16 -L-Lys, C 16 -D-Lys, C 16 -Gly-L-Lys and C 16 -Gly-D-Lys were all similar and positive, reflecting protonation of lysine at physiological pH. As such, all systems formed self-assembled cationic nanostructures, expected to bind polyanionic heparin or DNA the enantiomeric pairs existing as charge-dense identical (mirror-image) aggregates.
The DNA binding ability of C 16 -L-Lys and C 16 -D-Lys was initially quantified by displacement of ethidium bromide (EthBr) from its complex with DNA monitored by fluorescence spectroscopy in HEPES buffer (Fig. 2) . 17 The CE 50 value is the charge excess required for 50% displacement of EthBr, and EC 50 is the concentration of binder at the same point ( Table 2 ).
The EC 50 values are below the CACs of these ligands it is wellknown that polyanion binding can assist cationic lipid assembly by limiting electrostatic repulsion at the charged SAMul surface. 18 C 16 -L-Lys and C 16 -D-Lys had identical binding profiles ( Fig. 2A) and identical CE 50 values (Table 2) , suggesting these enantiomeric self-assemblies bind DNA in identical ways i.e., self-assembled nanoscale chirality has no significant impact on the molecular recognition interface. Conversely, the EthBr displacement assay indicated that the DNA binding ability of C 16 -Gly-L-Lys and C 16 -Gly-D-Lys was significantly different (Fig.  2C) , with the former having a CE 50 of 3.8 ± 0.7 but the latter having a CE 50 of 1.5 ± 0.1, indicating much better binding ( Table 2) . Clearly DNA has a significant preference between these enantiomeric assemblies. This would suggest that on introducing the glycine spacer, the lysine ligands are better able to express their chirality at the nanoscale binding interface, and as such, the molecular structure of each ligand matters, rather than the overall charge density of the SAMul nanostructure being the only factor controlling binding. Heparin binding was quantified using a Mallard Blue (MalB) competition assay in which the displacement of MalB from its complex with heparin, is monitored by UV-vis spectroscopy.
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The sigmoidal lineshape (Fig. 2) Fig. 2) with CE 50 values of 1.7 ± 0.2 and 1.1 ± 0.1, respectively (Table 2) . Chiral discrimination at the nanoscale binding interface has clearly, been switched on by the presence of the glycine spacer unit. As for DNA binding, C 16 -Gly-D-Lys binds heparin significantly more effectively than enantiomeric C 16 -Gly-L-Lys. We were concerned that binding to polyanions may significantly disrupt the nanoscale self-assemblies, leading to structural reorganisation. We therefore used TEM to image the SAMul nanostructures in the presence of DNA and heparin. In all cases, and for both families of ligand, self-assembled micellar objects appeared to remain intact and co-assemble with the polyanionic components into clustered hierarchical structured nano-assemblies ( Fig. 3 and ESI) . This hierarchical assembly is a result of close packing between polycationic micellar spheres and polyanionic chains. T -bound the TEM images arises from excess binder present in the samples. This imaging demonstrates that micellar stability is high and that self-assembly is not adversely affected by the presence of highly interactive polyanions.
Given the significant enantioselective binding differences induced by the introduction of a glycine spacer unit, we employed ITC titration methods to confirm these results and provide greater insight detailed methodology is presented in the ESI the SAMul systems were maintained well above their CAC throughout the titration in an attempt to avoid any thermodynamic contribution associated with de-micellisation. Binding isotherms are shown in Figure 4 and thermodynamic parameters are in Table 3 . Overall, heparin is bound more strongly than DNA primarily driven by the larger entropic term. In agreement with the EthBr/MalB displacement assays, the ITC results confirm that for C 16 -L-Lys and C 16 -D-Lys the selfassembled nanoscale chirality has no significant impact on the molecular recognition interface (Figs. 4A and B) . Further, and once again in agreement with the competition assays, ITC indicated significant polyanion binding differences between C 16 -Gly-L-Lys and C 16 -Gly-D-Lys (Figs. 4C and D) . Indeed, DNA displays a very clear preference for C 16 Please do not adjust margins
Please do not adjust margins enthalpic origin. This enhanced enthalpic effect is slightly offset by a smaller entropic gain for C 16 -Gly-D-Lys, but enthalpy dominates. As such, we suggest that specific ligand-polyanion interactions are optimised on the surface of the C 16 -Gly-D-Lys in comparison with C 16 -Gly-L-Lys. The lower enantioselectivity of heparin towards these SAMul systems compared with DNA may result from the more polydisperse nature of heparin leading to a less well-defined distribution of anionic binding sites. In DNA, the structure of the polymer is more welldefined, with anionic sites evenly and repetitively spaced down the helical backbone, hence potentially benefitting more from an appropriately structured binding partner. There are several potential reasons why the glycine spacer switches on enantioselective binding in this system. Most likely, as evidenced by DLS, is that the glycine spacer modifies the polarity and shape of the amphiphile and hence changes the self-assembled morphology, enabling the optimisation of the binding interface and greater selectivity. We can rule out any impact of charge density, as all systems have very similar zeta potentials. However, it is also possible that the additional glycine amide hydrogen bonding site may enable more specific interaction with the binding partner. Determining the relative importance of these different factors is the focus of a larger ongoing structure-activity relationship study.
Clearly, however, polyanion binding is sensitive to the way ligands are displayed on the surface of SAMul nanostructures. Understanding such effects is important in predicting and understanding the selectivity of binding processes at selfassembled bio-surfaces, such as cell membranes, as well as in optimising binding to nanoscale biological targets such as these clinically important polyanions.
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